A study from Children’s Hospital of Philadelphia and Children’s Hospital Colorado in Aurora found that esophageal stiffness could be a key biomarker for monitoring eosinophilic esophagitis (EoE) progression and identifying which patients may benefit most from current therapies, according to an Aug. 15 news release.
Researchers followed 112 pediatric patients aged 3 to 18 with EoE, using endoluminal functional imaging to measure esophageal distensibility. Patients with better-controlled inflammation showed less stiffening of the esophagus, while those with lower distensibility had higher odds of dysphagia and greater risk of stricture.
The findings, published in Gastroenterology, suggest that measuring esophageal stiffness may help predict disease complications and guide treatment strategies in children with EoE.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
